FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andreas Hamann

Research Profile

Disorders

Chemicals & Drugs

Physiology

Anatomy

Living Beings

Mouse

Concepts & Ideas

Cross-Sectional Studies

Co-author Network

Publications

TOP 3
Andreas Schlotterer; Andreas Hamann; Georgi Kukudov; Youssef Ibrahim; Britta Heckmann; Farastuk Bozorgmehr; Michael Pfeiffer; Harald Hutter; David Stern; Xue-Liang Du; Michael Brownlee; Angelika Bierhaus; Peter Nawroth; Michael Morcos
Apurinic/apyrimidinic endonuclease 1, p53, and thioredoxin are linked in control of aging in C. elegans.
Andreas Schlotterer; Georgi Kukudov; Farastuk Bozorgmehr; Harald Hutter; Xue-Liang Du; Dimitrios Oikonomou; Youssef Ibrahim; Friederike Pfisterer; Naila Rabbani; Paul Thornalley; Ahmed A R Sayed; Thomas Fleming; Per M Humpert; Vedat Schwenger; Martin Zeier; Andreas Hamann; David Stern; Michael Brownlee; Angelika Bierhaus; Peter Nawroth; Michael Morcos
C. elegans as model for the study of high glucose- mediated life span reduction.
Gottfried Rudofsky; Andreas Schlotterer; Peter Reismann; J Engel; Ingo A Grafe; Jörg Tafel; Michael Morcos; Per M Humpert; Peter Nawroth; Angelika Bierhaus; Andreas Hamann
The -174G>C IL-6 gene promoter polymorphism and diabetic microvascular complications.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andreas Hamann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Andreas Schlotterer; Andreas Hamann; Georgi Kukudov; Youssef Ibrahim; Britta Heckmann; Farastuk Bozorgmehr; Michael Pfeiffer; Harald Hutter; David Stern; Xue-Liang Du; Michael Brownlee; Angelika Bierhaus; Peter Nawroth; Michael Morcos
Apurinic/apyrimidinic endonuclease 1, p53, and thioredoxin are linked in control of aging in C. elegans.
Aging cell 2010;9(3):420-32.
2009: Andreas Schlotterer; Georgi Kukudov; Farastuk Bozorgmehr; Harald Hutter; Xue-Liang Du; Dimitrios Oikonomou; Youssef Ibrahim; Friederike Pfisterer; Naila Rabbani; Paul Thornalley; Ahmed A R Sayed; Thomas Fleming; Per M Humpert; Vedat Schwenger; Martin Zeier; Andreas Hamann; David Stern; Michael Brownlee; Angelika Bierhaus; Peter Nawroth; Michael Morcos
C. elegans as model for the study of high glucose- mediated life span reduction.
Diabetes 2009;58(11):2450-6.
2009: Gottfried Rudofsky; Andreas Schlotterer; Peter Reismann; J Engel; Ingo A Grafe; Jörg Tafel; Michael Morcos; Per M Humpert; Peter Nawroth; Angelika Bierhaus; Andreas Hamann
The -174G>C IL-6 gene promoter polymorphism and diabetic microvascular complications.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2009;41(4):308-13.
2008: Michael Morcos; Andreas Schlotterer; Ahmed A R Sayed; G Kukudov; D Oikomonou; Y Ibrahim; F Pfisterer; J Schneider; F Bozorgmehr; Gottfried Rudofsky; Vedat Schwenger; R Kientsch-Engels; Andreas Hamann; Martin Zeier; Klaus A Dugi; Benito A Yard; Per M Humpert; F van der Woude; Peter P Nawroth; Angelika Bierhaus
Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2008;40(11):752-9.
2008: Maximilian von Eynatten; Per M Humpert; Annabelle Bluemm; Philipp Lepper; Andreas Hamann; Bruno Allolio; Peter P Nawroth; Angelika Bierhaus; Klaus A Dugi
High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men.
Atherosclerosis 2008;199(1):123-8.
2008: Maximilian von Eynatten; Andreas Hamann; Dorothee Twardella; Peter P Nawroth; Hermann Brenner; Dietrich Rothenbacher
Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease.
European heart journal 2008;29(10):1307-15.
2008: Michael Morcos; Xue-Liang Du; Friederike Pfisterer; Harald Hutter; Ahmed A R Sayed; Paul Thornalley; Naila Ahmed; John W Baynes; Suzanne R Thorpe; Georgi Kukudov; Andreas Schlotterer; Farastuk Bozorgmehr; Randa Abd El Baki; David M Stern; Frank Moehrlen; Youssef Ibrahim; Dimitrios Oikonomou; Andreas Hamann; Christian Becker; Martin Zeier; Vedat Schwenger; Nexhat Miftari; Per Humpert; Hans-Peter Hammes; Markus Buechler; Angelika Bierhaus; Michael Brownlee; Peter P Nawroth
Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans.
Aging cell 2008;7(2):260-9.
2008: Andreas Hamann; J Garcia-Puig; G Paul; J Donaldson; M Stewart
Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2008;116(1):6-13.
2008: Gottfried Rudofsky; Andreas Schlotterer; Per M Humpert; Jörg Tafel; Michael Morcos; Peter P Nawroth; Angelika Bierhaus; Andreas Hamann
A M55V polymorphism in the SUMO4 gene is associated with a reduced prevalence of diabetic retinopathy in patients with Type 1 diabetes.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2008;116(1):14-7.
2007: Gottfried Rudofsky; Peter Reismann; Ingo A Grafe; Ilze Konrade; Zdenka Djuric; Jörg Tafel; S Buchbinder; Markus Zorn; Per M Humpert; Andreas Hamann; Michael Morcos; Peter P Nawroth; Angelika Bierhaus
Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2007;39(9):665-71.
2007: Gottfried Rudofsky; Andreas Schlotterer; Peter P Nawroth; Angelika Bierhaus; Andreas Hamann
Comment on: Lin et al. (2007) SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes: Diabetes 56: 1177-1180.
Diabetes 2007;56(8):e11; author reply e12-3.
2007: Per M Humpert; Stefan Kopf; Zdenka Djuric; K Laine; Grigorios Korosoglou; Gottfried Rudofsky; Andreas Hamann; Michael Morcos; Maximilian von Eynatten; Peter P Nawroth; Angelika Bierhaus
Levels of three distinct p75 neurotrophin receptor forms found in human plasma are altered in type 2 diabetic patients.
Diabetologia 2007;50(7):1517-22.
2007: Michael Morcos; Berthold Fohr; Jörg Tafel; F Pfisterer; Andreas Hamann; Per M Humpert; H Bode; Vedat Schwenger; M Zeier; C Becker; Christian Kasperk; Tobias Schilling; Hans-Peter Hammes; Angelika Bierhaus; Peter P Nawroth
Long-term treatment of central Cushing's syndrome with rosiglitazone.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2007;115(5):292-7.
2007: Gottfried Rudofsky; A Schrödter; O E Voron'ko; Andreas Schlotterer; Per M Humpert; Jörg Tafel; Peter P Nawroth; Angelika Bierhaus; Andreas Hamann
Promoter polymorphisms of UCP1, UCP2, and UCP3 are not associated with diabetic microvascular complications in type 2 diabetes.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2007;39(4):306-9.
2006: Nils Hansen-Algenstaedt; Petra Algenstaedt; Christian Schaefer; Andreas Hamann; Lars Wolfram; G Cingöz; Nerbil Kilic; Britta Schwarzloh; M Schroeder; Claudia Joscheck; Lothar Wiesner; Wolfgang Rüther; Süleyman Ergün
Neural driven angiogenesis by overexpression of nerve growth factor.
Histochemistry and cell biology 2006;125(6):637-49.
2006: Maximilian von Eynatten; Andreas Hamann; Dorothee Twardella; Peter P Nawroth; Hermann Brenner; Dietrich Rothenbacher
Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease.
Clinical chemistry 2006;52(5):853-9.
2006: Gottfried Rudofsky; Antonia Schroedter; Andreas Schlotterer; Olga E Voron'ko; Martin Schlimme; Jörg Tafel; Berend Isermann; Per M Humpert; Michael Morcos; Angelika Bierhaus; Peter P Nawroth; Andreas Hamann
Functional polymorphisms of UCP2 and UCP3 are associated with a reduced prevalence of diabetic neuropathy in patients with type 1 diabetes.
Diabetes care 2006;29(1):89-94.
2005: Jiang Chen; Michael Kasper; Tobias Heck; Katsumi Nakagawa; Per M Humpert; Ling Bai; Gang Wu; Youming Zhang; Thomas Luther; Martin Andrassy; Stephan Schiekofer; Andreas Hamann; Michael Morcos; Baoshen Chen; David M Stern; Peter P Nawroth; Angelika Bierhaus
Tissue factor as a link between wounding and tissue repair.
Diabetes 2005;54(7):2143-54.
2005: Gottfried Rudofsky; Martin Schlimme; Andreas Schlotterer; Maximilian von Eynatten; Peter Reismann; Jörg Tafel; Ingo A Grafe; Michael Morcos; Peter Nawroth; Angelika Bierhaus; Andreas Hamann
No association of the 94T/G polymorphism in the adiponectin gene with diabetic complications.
Diabetes, obesity & metabolism 2005;7(4):455-9.
2005: Per M Humpert; Renate Neuwirth; Marco J Battista; Olga Voronko; Maximilian von Eynatten; Ilze Konrade; Gottfried Rudofsky; Thoralf Wendt; Andreas Hamann; Michael Morcos; Peter P Nawroth; Angelika Bierhaus
SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes.
Diabetes care 2005;28(4):934-6.
2005: Maximilian von Eynatten; Jochen G Schneider; Senad Hadziselimovic; Andreas Hamann; Angelika Bierhaus; Peter P Nawroth; Klaus A Dugi
Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes.
Diabetes care 2005;28(3):754-5.
2004: Maximilian von Eynatten; Jochen G Schneider; Per M Humpert; Gottfried Rudofsky; Nikolaus Schmidt; Patrizia Barosch; Andreas Hamann; Michael Morcos; Jörg Kreuzer; Angelika Bierhaus; Peter P Nawroth; Klaus A Dugi
Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance.
Diabetes care 2004;27(12):2925-9.
2004: Andreas Hamann; Michael Morcos; Peter Nawroth
[Oral diabetes treatment. Which substance is indicated at which time?].
Der Internist 2004;45(12):1356-63.
2004: Jörg Tafel; I Branscheid; B Skwarna; Martin Schlimme; Michael Morcos; Petra Algenstaedt; A Hinney; J Hebebrand; Peter Nawroth; Andreas Hamann
Variants in the human beta 1-, beta 2-, and beta 3-adrenergic receptor genes are not associated with morbid obesity in children and adolescents.
Diabetes, obesity & metabolism 2004;6(6):452-5.
2004: Gottfried Rudofsky; Peter Reismann; Stephan Schiekofer; Dmitry Petrov; Per M Humpert; Berend Isermann; C Müller-Hoff; T-P Thai; S Lichtenstein; U Bärtsch; Andreas Hamann; Peter Nawroth; M von Eynatten; Angelika Bierhaus
Reduction of postprandial hyperglycemia in patients with type 2 diabetes reduces NF-kappaB activation in PBMCs.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2004;36(9):630-8.
2004: Berend Isermann; Angelika Bierhaus; Per M Humpert; Gottfried Rudofsky; Triantafyllos Chavakis; Robert A Ritzel; Thoralf Wendt; Michael Morcos; Christian Kasperk; Andreas Hamann; Peter P Nawroth
[AGE-RAGE: a hypothesis or a mechanism?].
Herz 2004;29(5):504-9.
2004: Jochen G Schneider; Maximilian von Eynatten; Klaus G Parhofer; Jan E Volkmer; Stephan Schiekofer; Andreas Hamann; Peter P Nawroth; Klaus A Dugi
Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo.
Atherosclerosis 2004;175(2):325-31.
2004: Peter Reismann; Christoph Lichy; Gottfried Rudofsky; Per M Humpert; Just Genius; Tuan-Dong Si; Christof E Dörfer; Armin J Grau; Andreas Hamann; Werner Hacke; Peter P Nawroth; Angelika Bierhaus
Lack of association between polymorphisms of the toll-like receptor 4 gene and cerebral ischemia.
Journal of neurology 2004;251(7):853-8.
2004: Wulf Hildebrandt; Andreas Hamann; Holger Krakowski-Roosen; Ralf Kinscherf; Klaus A Dugi; Roland Sauer; Sabrina Lacher; Nuria Nöbel; Anne Bodens; Vassiliki Bellou; Lutz Edler; Peter Nawroth; Wulf Dröge
Effect of thiol antioxidant on body fat and insulin reactivity.
Journal of molecular medicine (Berlin, Germany) 2004;82(5):336-44.
2004: Gottfried Rudofsky; Berend Isermann; Tobias Schilling; Stephan Schiekofer; Martin Andrassy; Jochen G Schneider; Michael Morcos; Per M Humpert; Ahmed A R Sayed; Steffen Witte; Walter Renn; M Pfohl; Andreas Hamann; Valery V Nosikov; Erwin Schleicher; Hans-Ulrich Häring; G Rudofsky; Eberhard Ritz; Peter P Nawroth; Angelika Bierhaus
A 63bp deletion in the promoter of rage correlates with a decreased risk for nephropathy in patients with type 2 diabetes.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2004;112(3):135-41.
2004: Gottfried Rudofsky; Peter Reismann; Steffen Witte; Per M Humpert; Berend Isermann; Triantafyllos Chavakis; Jörg Tafel; Valery V Nosikov; Andreas Hamann; Peter Nawroth; Angelika Bierhaus
Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes.
Diabetes care 2004;27(1):179-83.
2003: Petra Algenstaedt; S Daneshi; Britta Schwarzloh; N Hennigs; Andreas Hamann; Nils Hansen-Algenstaedt; U Beisiegel
Therapeutic dose of HIV-1 protease inhibitor saquinavir does not permanently influence early insulin signaling.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2003;111(8):491-8.
2003: Angelika Bierhaus; Per M Humpert; Gottfried Rudofsky; Thoralf Wendt; Michael Morcos; Andreas Hamann; Peter P Nawroth
New treatments for diabetic neuropathy: pathogenetically oriented treatment.
Current diabetes reports 2003;3(6):452-8.
2003: Andreas Hamann; Stephan Matthaei; Christoph Rosak; Louise Silvestre
A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes.
Diabetes care 2003;26(6):1738-44.
2003: Petra Algenstaedt; Christian Schaefer; Tanja Biermann; Andreas Hamann; Britta Schwarzloh; Heiner Greten; Wolfgang Rüther; Nils Hansen-Algenstaedt
Microvascular alterations in diabetic mice correlate with level of hyperglycemia.
Diabetes 2003;52(2):542-9.
2003: Li Yuan; Reinhard Ziegler; Andreas Hamann
Metformin modulates insulin post-receptor signaling transduction in chronically insulin-treated Hep G2 cells.
Acta pharmacologica Sinica 2003;24(1):55-60.
2002: Michael Morcos; Ahmed A R Sayed; Angelika Bierhaus; Benito A Yard; Rüdiger Waldherr; Wolfgang Merz; Ingrid Kloeting; Erwin Schleicher; Stefani Mentz; Randa F Abd el Baki; Hans Tritschler; Michael Kasper; Vedat Schwenger; Andreas Hamann; Klaus A Dugi; Ann Marie Schmidt; David M Stern; Reinhard Ziegler; Hans U Haering; Martin Andrassy; Fokko J van der Woude; Peter P Nawroth
Activation of tubular epithelial cells in diabetic nephropathy.
Diabetes 2002;51(12):3532-44.
2002: Jochen G Schneider; Nicole Tilly; Thomas Hierl; Ulrike Sommer; Andreas Hamann; Klaus A Dugi; Gudrun Leidig-Bruckner; Christian Kasperk
Elevated plasma endothelin-1 levels in diabetes mellitus.
American journal of hypertension 2002;15(11):967-72.
2002: Andreas Hamann; Arya Sharma
Genetics of obesity and obesity-related hypertension.
Seminars in nephrology 2002;22(2):100-4.
2002: Jochen Schneider; Jörg Kreuzer; Andreas Hamann; Peter P Nawroth; Klaus A Dugi
The proline 12 alanine substitution in the peroxisome proliferator--activated receptor-gamma2 gene is associated with lower lipoprotein lipase activity in vivo.
Diabetes 2002;51(3):867-70.
2002: Li Yuan; Reinhard Ziegler; Andreas Hamann
Chronic hyperinsulinism induced down-regulation of insulin post-receptor signaling transduction in Hep G2 cells.
Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 2002;22(4):313-6.
2001: Andreas Hamann; C Disque; H Münzberg; Jörg Tafel; A Hinney; H Mayer; J Hebebrand; R Ziegler
Mutational screening of the human type II deiodinase gene.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2001;33(8):508-9.
2001: Andreas Hamann; H Münzberg; Petra Algenstaedt; Jörg Tafel
[Molecular principles of obesity].
Herz 2001;26(3):178-84.
2001: Andreas Hamann; H Münzberg; Jörg Tafel; R Ziegler
[Some may feel hot: significance of thermogenesis for energy metabolism and the treatment of obesity].
Deutsche medizinische Wochenschrift (1946) 2001;126(9):241-6.
2001: Andreas Hamann; C Brieske; Jörg Tafel; P Buttron; Britta Schwarzloh; H Münzberg; A Hinney; H Mayer; W Siegfried; J Hebebrand; Heiner Greten; Petra Algenstaedt; R Ziegler
Identification of a deletion variant in the gene encoding the human alpha(2A)-adrenergic receptor.
European journal of endocrinology / European Federation of Endocrine Societies 2001;144(3):291-5.
2000: Andreas Hamann; Jörg Tafel; H Münzberg
[Etiology of overweight and obesity].
Therapeutische Umschau. Revue thérapeutique 2000;57(8):482-7.
2000: Christiana Kausch; Andreas Hamann; I Uphues; A Niendorf; Dirk Müller-Wieland; Hans-Georg Joost; Petra Algenstaedt; M Dreyer; H W Rüdiger; Hans-Ulrich Häring; Jürgen Eckel; Stephan Matthaei
Association of impaired phosphatidylinositol 3-kinase activity in GLUT1-containing vesicles with malinsertion of glucose transporters into the plasma membrane of fibroblasts from a patient with severe insulin resistance and clinical features of Werner syndrome.
The Journal of clinical endocrinology and metabolism 2000;85(2):905-18.
1999: Andreas Hamann; H Münzberg; P Buttron; B Büsing; A Hinney; H Mayer; W Siegfried; J Hebebrand; Heiner Greten
Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects.
European journal of endocrinology / European Federation of Endocrine Societies 1999;141(1):90-2.
1999: Andreas Hamann; B Büsing; H Münzberg; Andreas de Weerth; A Hinney; H Mayer; W Siegfried; J Hebebrand; Heiner Greten
Missense variants in the human cholecystokinin type A receptor gene: no evidence for association with early-onset obesity.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1999;31(4):287-8.
1999: Christiana Kausch; C Bergemann; Andreas Hamann; Stephan Matthaei
Insulin-mediated pseudoacromegaly in a patient with severe insulin resistance: association of defective insulin-stimulated glucose transport with impaired phosphatidylinositol 3-kinase activity in fibroblasts.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1999;107(2):148-54.
1998: H Münzberg; Jörg Tafel; B Büsing; A Hinney; A Ziegler; H Mayer; W Siegfried; Stephan Matthaei; Heiner Greten; J Hebebrand; Andreas Hamann
Screening for variability in the ciliary neurotrophic factor (CNTF) gene: no evidence for association with human obesity.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1998;106(2):108-12.
1998: Andreas Hamann; J S Flier; B B Lowell
Obesity after genetic ablation of brown adipose tissue.
Zeitschrift für Ernährungswissenschaft 1998;37 Suppl 1():1-7.
1997: Andreas Hamann; Stephan Matthaei
[Progress in obesity research].
Medizinische Monatsschrift für Pharmazeuten 1997;20(10):264-70.
1997: Andreas Hamann; B Büsing; Christiana Kausch; J Ertl; G Preibisch; Heiner Greten; Stephan Matthaei
Chronic leptin treatment does not prevent the development of obesity in transgenic mice with brown fat deficiency.
Diabetologia 1997;40(7):810-5.
1997: Stephan Matthaei; Andreas Hamann
[Current insulin therapy. Treatment with new short-acting and retard insulin analogs].
Fortschritte der Medizin 1997;115(12):35-6, 39.
1996: Andreas Hamann; Stephan Matthaei
Regulation of energy balance by leptin.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1996;104(4):293-300.
1995: Andreas Hamann; H Benecke; Y Le Marchand-Brustel; VS Susulic; Bradford B Lowell; Jeffrey S Flier
Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat.
Diabetes 1995;44(11):1266-73.
1995: Andreas Hamann; Stephan Matthaei; Heiner Greten
[Through thick and thin: current aspects of obesity research].
Deutsche medizinische Wochenschrift (1946) 1995;120(27):971-5.
1995: Stephan Matthaei; B Trost; Andreas Hamann; Christiana Kausch; H Benecke; Heiner Greten; Wolfgang Höppner; Harald H Klein
Effect of in vivo thyroid hormone status on insulin signalling and GLUT1 and GLUT4 glucose transport systems in rat adipocytes.
The Journal of endocrinology 1995;144(2):347-57.
1993: Andreas Hamann; H Benecke; Heiner Greten; Stephan Matthaei
Metformin increases glucose transporter protein and gene expression in human fibroblasts.
Biochemical and biophysical research communications 1993;196(1):382-7.
1993: Stephan Matthaei; J P Reibold; Andreas Hamann; H Benecke; H U Häring; Heiner Greten; Harald H Klein
In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes.
Endocrinology 1993;133(1):304-11.
1992: Stephan Matthaei; Andreas Hamann; Harald H Klein; H Benecke; G Kreymann; Jeffrey S Flier; Heiner Greten
Evidence that metformin increases insulin-stimulated glucose transport by potentiating insulin-induced translocation of glucose transporters from an intracellular pool to the cell surface in rat adipocytes.
Hormone and metabolic research. Supplement series 1992;26():34-41.
1991: Stephan Matthaei; Andreas Hamann; Harald H Klein; H Benecke; G Kreymann; Jeffrey S Flier; Heiner Greten
Association of Metformin's effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes.
Diabetes 1991;40(7):850-7.
1990: Stephan Matthaei; H Benecke; Harald H Klein; Andreas Hamann; G Kreymann; Heiner Greten
Potential mechanism of insulin resistance in ageing: impaired insulin-stimulated glucose transport due to a depletion of the intracellular pool of glucose transporters in Fischer rat adipocytes.
The Journal of endocrinology 1990;126(1):99-107.